SlideShare a Scribd company logo
Combat
Toxicology
Frank W. Meissner, MD, FACP, FACC, FCCP
Emergency Medicine
History
●Iran - Iraq War emphasized the risk of
chemical weapons on the modern
battlefield
●Planning for ChemWar, complicated
Desert Storm Operations
●Recent Urban terrorist attacks in Japan
have emphasized the THREAT
Large scale conventional
combat operations
●Air Force bases susceptible to chemical
attack
●Geographicaly fixed & limited targets
●Chemical agent concentrations are in the
realm of tactical feasibility
●High value targets ideal for suprise
attack
Large scale conventional
combat operations
●High probability of disruption of combat
operations
●High density of personnel and technically
complicated resources
●Communication Nodes, Command and
Control, Combat Analysis
●Non-combatant philosophy of technically
oriented staff
Ground attack/defense forces
fewer susceptibilities
●Density of personnel much less than Air
Force Base
●High penalties for attacker - mobility and
fields of fire/observation
Ground attack/defense forces
fewer susceptibilities
●Uncertainty of defenders position in time
and space
●Larger areas to saturate with the
chemical munition
●Chemical agent concentrations are lower
than in the fixed target
Toxicological definitions
●Dose: Quantity of compound (mg/kg)
●Vaporized chem-agent dose = conc *
time (exposure)
Ct (mg*min/m3)
●LD50: Dose that 50% population dies
●ID50: Dose that 50% of population
incapacited
Routes of absorption
●Gases, vapors, aerosols absorbed in
total respiratory tract
●Aerosol particles > 5µ tend to be
retained in upper respiratory tract
●Aerosol particles < 1 µ tend to be in
exchanged gases
Routes of absorption
●Liquids absorbed from skin surface &
mucous membranes
●Chemical agents contaminate food
stuffs/water - GI tract absorption
Classes of Chemical Weapons
●Nerve agents
●Vesicants
●Lung damaging agents
●Cyanogen agents
●Incapacitating agents
Nerve Agents - History
●At end of WWII stocks of new type
German chemical weapon discovered
●This compound labeled by the Germans
as TABUN
●Entire group of agents developed from
this prototypical compound
Physical & chemical properties
●Organophosphorus esters related to
insecticides such as parathion
●These compounds are liquids varying in
volatility
●Volatility range between petrol and heavy
lubricating oil
●Freezing points approx -40° C
Physical & chemical properties
●Appearance- liquid nerve agents are
pale yellow to colorless
●Almost odorless
●Stability- moderate solubility in H2O/high
solubility in lipids
●Rapidly destroyed strong alkalies &
chlorinating compounds
Toxicity
●Depends on animal species and route of
entry
●IV in rabbits LD50 10-20 µgm/kg (GA
80µgm/kg)
●Percutaneous toxicity dependent on
volatility
○25 µgm/kg for VX
○20 µgm/kg for GB
Inhalation route
●LCt50 of G agents in rats - 200
mg*min/m3 for 10 minutes
●LCt50 of G agents for man 100
mg*min/m3
○Approx 400 mg needed to kill 50 % theater
audience
Inhalation route
●LCt50 of VX aerosol for man 50
mg*min/m3
●ID50 aproximately 50% of LD50 or LCt50
Acetylcholine
●Most ubiquitious and important neural
transmitter
●Motor end plate
●Muscarinic receptor
●Nicotinic receptor
Parasympathomimetic (muscarinic) receptor
●Nonvascular smooth muscle
○Increased propulsive gastrointestinal activity
("the shits", "the barfs" )
○Bladder constriction ("the wizzes")
○Bronchiole constriction ("the wheezes")
○Pupillary constriction ("the squints")
Parasympathomimetic (muscarinic) receptor
●Exocrine glands
○Increase in salivation ("the drools")
○Increase in perspiration ("the sweats")
○Increase in rhinorrhea ("the drips")
●Cardiovascular
○UNPREDICTABLE EFFECTS
Sympathomimetic (nicotinic) receptor
●Effects first described for the tobacco
alkaloid nicotine
●Cardiovascular effects
○Vasoconstriction & cardiac stimulation
○Liberates adrenal medullary amines
(catecholamines)
Voluntary nerve-muscle junction
●Voluntary muscle contraction
Acetylcholinesterase
●Enzyme found in postsynaptic side of
neuromuscular junction
●Action of the enyzme
●Inactivates Acetylcholine
Cholinesterase inhibitors
●Reversible inhibitors
○Used for a number of medical indications
Postoperative ileus and urinary retention
Glaucoma
Termination of the action of curare
Myasthenia Gravis
Cholinesterase inhibitors
●Irreversible inhibitors: organophosphates
●Insecticides, e.g. malathion
●Nerve gases
Signs and symptoms
●Irreversible inhibition of cholinesterase
inhibitor
●Results in uncontrolled stimulation at
acetylcholine receptors
Symptoms of acetylcholine action
●Mild to moderate exposure
○"the squints"; "the drools"; "the sweats"; "the
drips"; "the wheezes"
●Severe exposure
○"the barfs"; "the shits"; "the wizzes";"the
drops" (syncope)
○"the shakes" (seizures); "the end"
(respiratory arrest & death)
Treatment
●General supportive care & BCLS/ACLS
●Ventilator support & cardiac monitoring &
inhaled beta-agonist
●Requirements for optimal care of one
apneic, seizing, hypoxic patient
○one medical corps officer & two support
personnel
Atropine -the first line of
therapy
●A potent acetylcholine inhibitor
●Acts by competitive inhibition of Ach at
the neuromuscular junction
○Atropine Dosage
2 mg IV q 5 minutes until signs of atropinization
Effective Atropinization
●Red face
●Dry mouth
●Mydriasis (wide-open pupils)
●Tachycardia
Pralidoxime chloride- reserve forces
●Partially reactivates acetylcholinesterase
●Effective within first 36 hours of exposure
●Unlike atropine has actions at nicotinic & muscarinic
receptors helps relieve skeletal neuromuscular
blockade
●No reversal of inhibition after exposure to GD (Soman)
Pralidoxime chloride
●Dose
○Pralidoxime moderate poisoning
1 gram 2-Pam Cl in 10 ml at 500mg/min IV
○Pralidoxime severe poisoning
2 gram 2-Pam Cl in 10 ml at 500mg/min IV
●Precautions
○Hypertension during infusion self-limited but
may be severe, thus, monitor B/P
"The Chemical Battlefield"
Acetylcholine
receptor
P
r
e
s
y
n
a
p
t
i
c
Ach
Ach-esteras
e
Cholinesterase
inhibitor
Pralidoxim
e
Atropine
Vesicants (Blister Agents)-
History
●Mustard most well known agent
●First synthesized 1822
●Vesicant properties=> mid-19th century
●First employed as a chemical weapon
near Ypres 1917
●HD symbol in NATO nomenclature
Properties
●Mustards are liquid agents with high
persistence in temperate and cold
climates
●Toxicity
○LCt50 vapor, inhalation (mg*min/m3)
HD - 1500
HN1 - 1500
HN2 - 3000
HN3 - 1500
Toxicity
●LCt50 vapor, skin (mg*min/m3)
HD - 10000
HN1 - 20000
HN3 - 10000
●LD50 liquid, skin (mg/kg) 1 hr contact time
HD - 60
HN1 - 10
●Total absorption of 6 µg/cm2 causes 50% of
white human subjects to blister
Mode of action
●Alkylating and electrophylic properties
●Modify the structure of nucleic acids,
cellular membranes, and proteins
●Overall reactions of mustard with cellular
molecules
●Used clinically as chemotherapy agents
Signs and symptoms
●Cutaneous syndrome- divided into 4
phases
Latent
●Skin penetration not noticed because
painless
●Average duration of 4-8 hrs after
exposure
●Duration of latent period dependent on
humidity, temperature, and dose
Erythema
●Intensive itching in association with
erythema
Vesication
●Begins 12 - 48 hours after exposure
●Coalescence of vesicles form large
blisters
●Blisters generally more than 1 cm2 in
area
Necrosis
●Blisters rupture spontaneously turn into
suppurating & necrotic wounds
●Prolonged period of healing of these
wounds may take as long as weeks to
months
Ocular syndrome
●1-4 hours after exposure
●Intense pain, photophobia, and
blepharospasm
●Usually blistering of external ocular
structures and periorbital structures
●May result in blindness
Respiratory tract
●Mustard attacks all mucous membranes
●Latent period 4-6 hours in duration
●Profuse nasal secretions, burning pain in
throat
●Abundantly productive cough
●ARDS
Gastrointestinal tract
●Nausea & vomiting
●Pain
●Bloody diarrhea
●Shock
Systemic effects
●Headache, N/V, anorexia, epigastric
pain, leukopenia, anemia
●CNS depression, seizures
●Cardiac arrythmias, Cardiac arrest
Other Vesicants
●Lewisite
○Arsenical
○Similar clinical picture
○Reduced period of latency
Halogenated oximes
●CX most toxic of this class of agents
●No period of latency
●Low boiling point limits this agents
military usefulness
Treatment
●Prevention of exposure
●Supportive care & meticulous nursing
●No specific therapy
Choking Agents- History
●Phosgene(CG) first used combat in 1915
●80% of all combat causalities in WWI
●CG is the only significant chemical threat
in this class
Physical & chemical properties
●Colorless gas under conditions of
ordinary temperature & atmospheric
pressure
●Odor of newly mown hay
●Limit of perception by smell 22 mg/m3
Toxicity
●Minimal concentration irritation of eyes
and throat 12.5-20 mg/m3
●Serious lung damage-inhalation 50
mg/m3 over an hour period
●200 mg/m3 rapidly fatal
●LCt50 = 3000 mg*min/m3
Mode of action
●Poorly understood=> diffuse damage to
pulmonary membranes
●Severe pulmonary edema- 12-24 hrs
post exposure
●Lethal exposure usually results in death
within 24 hrs
●SurvivalX2-3 days=> good prognosis
Signs and symptoms
●Immediate exposure symptoms
○Lacryamation, dry throat, coughing,
tightness in chest
○Nausea & vomiting, headache
●Latent period of 2-6 hours after exposure
○Hypoxia, cyanosis, and productive cough
○Shock and respiratory arrest
Treatment
●General supportive care
●Enriched O2 & ventilator support with
PEEP for fulminant cases
●Rx the patient as an ARDS patient
Cyanogen Agents- History
●Cyanogen halides only compounds of
military importance
●WWI hydrocyanic acid & cyanogen
chloride used by French
●Cyanogen bromide used by Austrians
Properties
●Physical & Chemical
○Vapor at room temperature
○smell of "bitter almonds"
●Toxicity
○Percutaneous LD50 100mg/kg
○Ocular LD50 1-2 mg/kg
○Oral LD50 .9 mg/kg
Haber's Law= LCt50 is a constant
●Blood agents do not follow Haber's Law
○LCt50 600 mg*min/m3 15 sec exposure
○LCt50 1000 mg*min/m3 60 sec exposure
○LCt50 2000 mg*min/m3 10 min exposure
○LCt50 4500 mg*min/m3 30 min exposure
●Time concentration variablity limit their
military usefulness
Mode of action
●Cyanide high affinity- Fe++ in ferric state
●Binds to cytochrome oxidase
●Inhibits electron transport chain
●Intracellular hypoxia
●O2 cannot be utilized within the cell
●Progressive severe Acidosis
Signs and symptoms
●Tachypnea
●Headache
●Convulsions
●"bitter almond" smell on breath
Treatment
●Amyl nitrate by inhalation
●Sodium nitrate(4-5 mg/kg or 10 ml 3%
solution in 1 min) by infusion
●Converts hemoglobin=> methemoglobin
●Competes for cyanide ion
Treatment
●Thiosulfate (50ml of a 25% aqueous
solution(200 mg/kg))
●Thiocyanate excreted in urine
●Hyperbaric oxygen adjunctive therapy for
drug therapy
Incapacitants- History
Not known to be previously
used in combat
CNS Depressants
●BZ cholinergic compound
○Toxicology
Dose ≤ 1mg/kg can cause delirium of several day
duration
Safety margin (lethal/incapacitating dose)= 30
●Mode of action
○Similiar to atropine
BZ- Signs & symptoms
●Dry as a bone
●Hot as a hare
●Mad as a hatter
BZ- Treatment
●High risk for heat stroke as patient
cannot sweat
●Physostigmine salicylate 1 mg/20 kg IM
repeat dose in 40 min if inadequate
result
●Maintenance dose 2-5 mg po q 1-2 hrs
●Titrate therapy to HR = 70-80 bpm
Tetrahydrocannabinols
●Toxicity
○No deaths reported from this agent
○Synthetic analogs can have effects for days
after dose
●Mode of action
○Unknown
Tetrahydrocannabinols
●Signs & symptoms
○feelings of unreality, intensification of
sensations, difficulty in concentration
○lethargy, sedation, orthostatic hypotension
(synthetic analogs)
●Treatment
○No treatment necessary
CNS Stimulants- LSD & Mescaline
●Toxicity
○D-lysergic acid diethylamide most potent
biologicaly active indole
○Minimal dose 50 µgm
○Doses of 2-5 mg taken without sequelae
○Mescaline < potent toxic range 300-600 mg
○Max effects 2-3 hrs & further effects 4-8 hrs
LSD
●LSD is a serotonin antagonist
●Enhances neural activity in the reticular
activating system
○Signs & symptoms
Sympathetic stimulation,
Mental excitement
●Symptomatic treatment
Conclusions
●Chemical threat is REAL
●Weapons are cheap to make & utilize
●Terrorist threat is OBVIOUSLY high
●Air Force Bases @ increased risk
●Poor weapon against prepared troops in
the defense

More Related Content

Similar to Combat tox

Acute poisoning
Acute poisoningAcute poisoning
Acute poisoning
MUNIRTAREEN
 
.Quinolones -Dr.Jibachha Sah
.Quinolones -Dr.Jibachha Sah.Quinolones -Dr.Jibachha Sah
.Quinolones -Dr.Jibachha Sah
Dr. Jibachha Sah
 
Newer anti-platelets final.
Newer anti-platelets final.Newer anti-platelets final.
Newer anti-platelets final.
Dr Renju Ravi
 
Ototoxicity seminar
Ototoxicity seminarOtotoxicity seminar
Ototoxicity seminar
Suhasini Biyyapu
 
Deployment medicine
Deployment medicineDeployment medicine
Deployment medicine
Frank Meissner
 
ROUGH DRAFT PPT.pptx for pediatric anaesthesia
ROUGH DRAFT PPT.pptx for pediatric anaesthesiaROUGH DRAFT PPT.pptx for pediatric anaesthesia
ROUGH DRAFT PPT.pptx for pediatric anaesthesia
sivasankar sundar
 
Celphos poisoning
Celphos poisoningCelphos poisoning
Celphos poisoning
mohmeet
 
analgesics and corticosteroids
analgesics and corticosteroids analgesics and corticosteroids
analgesics and corticosteroids
Sanskriti Shah
 

Similar to Combat tox (8)

Acute poisoning
Acute poisoningAcute poisoning
Acute poisoning
 
.Quinolones -Dr.Jibachha Sah
.Quinolones -Dr.Jibachha Sah.Quinolones -Dr.Jibachha Sah
.Quinolones -Dr.Jibachha Sah
 
Newer anti-platelets final.
Newer anti-platelets final.Newer anti-platelets final.
Newer anti-platelets final.
 
Ototoxicity seminar
Ototoxicity seminarOtotoxicity seminar
Ototoxicity seminar
 
Deployment medicine
Deployment medicineDeployment medicine
Deployment medicine
 
ROUGH DRAFT PPT.pptx for pediatric anaesthesia
ROUGH DRAFT PPT.pptx for pediatric anaesthesiaROUGH DRAFT PPT.pptx for pediatric anaesthesia
ROUGH DRAFT PPT.pptx for pediatric anaesthesia
 
Celphos poisoning
Celphos poisoningCelphos poisoning
Celphos poisoning
 
analgesics and corticosteroids
analgesics and corticosteroids analgesics and corticosteroids
analgesics and corticosteroids
 

More from Frank Meissner

BigDataInMedicine.pptx
BigDataInMedicine.pptxBigDataInMedicine.pptx
BigDataInMedicine.pptx
Frank Meissner
 
Eating D/O
Eating D/OEating D/O
Eating D/O
Frank Meissner
 
Bipolar D/O
Bipolar D/O Bipolar D/O
Bipolar D/O
Frank Meissner
 
EKG Patterns of SCD - Can't Miss EKG Patterns for Generalist & Psychiatrist
EKG Patterns of SCD - Can't Miss EKG Patterns for Generalist & PsychiatristEKG Patterns of SCD - Can't Miss EKG Patterns for Generalist & Psychiatrist
EKG Patterns of SCD - Can't Miss EKG Patterns for Generalist & Psychiatrist
Frank Meissner
 
PE case
PE casePE case
Pediatric delirium
Pediatric deliriumPediatric delirium
Pediatric delirium
Frank Meissner
 
Taktosubo cardiomyopathy verona june2018
Taktosubo cardiomyopathy verona june2018Taktosubo cardiomyopathy verona june2018
Taktosubo cardiomyopathy verona june2018
Frank Meissner
 
Drug induced brugadda apa
Drug induced brugadda apaDrug induced brugadda apa
Drug induced brugadda apa
Frank Meissner
 
Curanderos presentation
Curanderos presentation Curanderos presentation
Curanderos presentation
Frank Meissner
 
Pills & Thrills
Pills & ThrillsPills & Thrills
Pills & Thrills
Frank Meissner
 
Verona sleep hx presentation
Verona sleep hx presentationVerona sleep hx presentation
Verona sleep hx presentation
Frank Meissner
 
Hemmorhagic fever zagreb
Hemmorhagic fever zagrebHemmorhagic fever zagreb
Hemmorhagic fever zagreb
Frank Meissner
 
Tropical cardiology
Tropical cardiologyTropical cardiology
Tropical cardiology
Frank Meissner
 
Schistomasis
SchistomasisSchistomasis
Schistomasis
Frank Meissner
 
Onchocerciasis
OnchocerciasisOnchocerciasis
Onchocerciasis
Frank Meissner
 
Malaria
MalariaMalaria
Visceral leishmanasis
Visceral leishmanasisVisceral leishmanasis
Visceral leishmanasis
Frank Meissner
 
Chest pain perals
Chest pain peralsChest pain perals
Chest pain perals
Frank Meissner
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
Frank Meissner
 
Critical Care Arrhythmia
Critical Care ArrhythmiaCritical Care Arrhythmia
Critical Care Arrhythmia
Frank Meissner
 

More from Frank Meissner (20)

BigDataInMedicine.pptx
BigDataInMedicine.pptxBigDataInMedicine.pptx
BigDataInMedicine.pptx
 
Eating D/O
Eating D/OEating D/O
Eating D/O
 
Bipolar D/O
Bipolar D/O Bipolar D/O
Bipolar D/O
 
EKG Patterns of SCD - Can't Miss EKG Patterns for Generalist & Psychiatrist
EKG Patterns of SCD - Can't Miss EKG Patterns for Generalist & PsychiatristEKG Patterns of SCD - Can't Miss EKG Patterns for Generalist & Psychiatrist
EKG Patterns of SCD - Can't Miss EKG Patterns for Generalist & Psychiatrist
 
PE case
PE casePE case
PE case
 
Pediatric delirium
Pediatric deliriumPediatric delirium
Pediatric delirium
 
Taktosubo cardiomyopathy verona june2018
Taktosubo cardiomyopathy verona june2018Taktosubo cardiomyopathy verona june2018
Taktosubo cardiomyopathy verona june2018
 
Drug induced brugadda apa
Drug induced brugadda apaDrug induced brugadda apa
Drug induced brugadda apa
 
Curanderos presentation
Curanderos presentation Curanderos presentation
Curanderos presentation
 
Pills & Thrills
Pills & ThrillsPills & Thrills
Pills & Thrills
 
Verona sleep hx presentation
Verona sleep hx presentationVerona sleep hx presentation
Verona sleep hx presentation
 
Hemmorhagic fever zagreb
Hemmorhagic fever zagrebHemmorhagic fever zagreb
Hemmorhagic fever zagreb
 
Tropical cardiology
Tropical cardiologyTropical cardiology
Tropical cardiology
 
Schistomasis
SchistomasisSchistomasis
Schistomasis
 
Onchocerciasis
OnchocerciasisOnchocerciasis
Onchocerciasis
 
Malaria
MalariaMalaria
Malaria
 
Visceral leishmanasis
Visceral leishmanasisVisceral leishmanasis
Visceral leishmanasis
 
Chest pain perals
Chest pain peralsChest pain perals
Chest pain perals
 
Cardiomyopathy
CardiomyopathyCardiomyopathy
Cardiomyopathy
 
Critical Care Arrhythmia
Critical Care ArrhythmiaCritical Care Arrhythmia
Critical Care Arrhythmia
 

Recently uploaded

OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
KafrELShiekh University
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Jim Jacob Roy
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
chiranthgowda16
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
DIVYANSHU740006
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 

Recently uploaded (20)

OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1OCT Training Course for clinical practice Part 1
OCT Training Course for clinical practice Part 1
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdfOsteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
 
Complementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLSComplementary feeding in infant IAP PROTOCOLS
Complementary feeding in infant IAP PROTOCOLS
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treatHistopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 

Combat tox

  • 1. Combat Toxicology Frank W. Meissner, MD, FACP, FACC, FCCP Emergency Medicine
  • 2. History ●Iran - Iraq War emphasized the risk of chemical weapons on the modern battlefield ●Planning for ChemWar, complicated Desert Storm Operations ●Recent Urban terrorist attacks in Japan have emphasized the THREAT
  • 3. Large scale conventional combat operations ●Air Force bases susceptible to chemical attack ●Geographicaly fixed & limited targets ●Chemical agent concentrations are in the realm of tactical feasibility ●High value targets ideal for suprise attack
  • 4. Large scale conventional combat operations ●High probability of disruption of combat operations ●High density of personnel and technically complicated resources ●Communication Nodes, Command and Control, Combat Analysis ●Non-combatant philosophy of technically oriented staff
  • 5. Ground attack/defense forces fewer susceptibilities ●Density of personnel much less than Air Force Base ●High penalties for attacker - mobility and fields of fire/observation
  • 6. Ground attack/defense forces fewer susceptibilities ●Uncertainty of defenders position in time and space ●Larger areas to saturate with the chemical munition ●Chemical agent concentrations are lower than in the fixed target
  • 7. Toxicological definitions ●Dose: Quantity of compound (mg/kg) ●Vaporized chem-agent dose = conc * time (exposure) Ct (mg*min/m3) ●LD50: Dose that 50% population dies ●ID50: Dose that 50% of population incapacited
  • 8. Routes of absorption ●Gases, vapors, aerosols absorbed in total respiratory tract ●Aerosol particles > 5µ tend to be retained in upper respiratory tract ●Aerosol particles < 1 µ tend to be in exchanged gases
  • 9. Routes of absorption ●Liquids absorbed from skin surface & mucous membranes ●Chemical agents contaminate food stuffs/water - GI tract absorption
  • 10. Classes of Chemical Weapons ●Nerve agents ●Vesicants ●Lung damaging agents ●Cyanogen agents ●Incapacitating agents
  • 11. Nerve Agents - History ●At end of WWII stocks of new type German chemical weapon discovered ●This compound labeled by the Germans as TABUN ●Entire group of agents developed from this prototypical compound
  • 12. Physical & chemical properties ●Organophosphorus esters related to insecticides such as parathion ●These compounds are liquids varying in volatility ●Volatility range between petrol and heavy lubricating oil ●Freezing points approx -40° C
  • 13. Physical & chemical properties ●Appearance- liquid nerve agents are pale yellow to colorless ●Almost odorless ●Stability- moderate solubility in H2O/high solubility in lipids ●Rapidly destroyed strong alkalies & chlorinating compounds
  • 14. Toxicity ●Depends on animal species and route of entry ●IV in rabbits LD50 10-20 µgm/kg (GA 80µgm/kg) ●Percutaneous toxicity dependent on volatility ○25 µgm/kg for VX ○20 µgm/kg for GB
  • 15. Inhalation route ●LCt50 of G agents in rats - 200 mg*min/m3 for 10 minutes ●LCt50 of G agents for man 100 mg*min/m3 ○Approx 400 mg needed to kill 50 % theater audience
  • 16. Inhalation route ●LCt50 of VX aerosol for man 50 mg*min/m3 ●ID50 aproximately 50% of LD50 or LCt50
  • 17. Acetylcholine ●Most ubiquitious and important neural transmitter ●Motor end plate ●Muscarinic receptor ●Nicotinic receptor
  • 18. Parasympathomimetic (muscarinic) receptor ●Nonvascular smooth muscle ○Increased propulsive gastrointestinal activity ("the shits", "the barfs" ) ○Bladder constriction ("the wizzes") ○Bronchiole constriction ("the wheezes") ○Pupillary constriction ("the squints")
  • 19. Parasympathomimetic (muscarinic) receptor ●Exocrine glands ○Increase in salivation ("the drools") ○Increase in perspiration ("the sweats") ○Increase in rhinorrhea ("the drips") ●Cardiovascular ○UNPREDICTABLE EFFECTS
  • 20. Sympathomimetic (nicotinic) receptor ●Effects first described for the tobacco alkaloid nicotine ●Cardiovascular effects ○Vasoconstriction & cardiac stimulation ○Liberates adrenal medullary amines (catecholamines)
  • 22. Acetylcholinesterase ●Enzyme found in postsynaptic side of neuromuscular junction ●Action of the enyzme ●Inactivates Acetylcholine
  • 23. Cholinesterase inhibitors ●Reversible inhibitors ○Used for a number of medical indications Postoperative ileus and urinary retention Glaucoma Termination of the action of curare Myasthenia Gravis
  • 24. Cholinesterase inhibitors ●Irreversible inhibitors: organophosphates ●Insecticides, e.g. malathion ●Nerve gases
  • 25. Signs and symptoms ●Irreversible inhibition of cholinesterase inhibitor ●Results in uncontrolled stimulation at acetylcholine receptors
  • 26. Symptoms of acetylcholine action ●Mild to moderate exposure ○"the squints"; "the drools"; "the sweats"; "the drips"; "the wheezes" ●Severe exposure ○"the barfs"; "the shits"; "the wizzes";"the drops" (syncope) ○"the shakes" (seizures); "the end" (respiratory arrest & death)
  • 27. Treatment ●General supportive care & BCLS/ACLS ●Ventilator support & cardiac monitoring & inhaled beta-agonist ●Requirements for optimal care of one apneic, seizing, hypoxic patient ○one medical corps officer & two support personnel
  • 28. Atropine -the first line of therapy ●A potent acetylcholine inhibitor ●Acts by competitive inhibition of Ach at the neuromuscular junction ○Atropine Dosage 2 mg IV q 5 minutes until signs of atropinization
  • 29. Effective Atropinization ●Red face ●Dry mouth ●Mydriasis (wide-open pupils) ●Tachycardia
  • 30. Pralidoxime chloride- reserve forces ●Partially reactivates acetylcholinesterase ●Effective within first 36 hours of exposure ●Unlike atropine has actions at nicotinic & muscarinic receptors helps relieve skeletal neuromuscular blockade ●No reversal of inhibition after exposure to GD (Soman)
  • 31. Pralidoxime chloride ●Dose ○Pralidoxime moderate poisoning 1 gram 2-Pam Cl in 10 ml at 500mg/min IV ○Pralidoxime severe poisoning 2 gram 2-Pam Cl in 10 ml at 500mg/min IV ●Precautions ○Hypertension during infusion self-limited but may be severe, thus, monitor B/P
  • 33. Vesicants (Blister Agents)- History ●Mustard most well known agent ●First synthesized 1822 ●Vesicant properties=> mid-19th century ●First employed as a chemical weapon near Ypres 1917 ●HD symbol in NATO nomenclature
  • 34. Properties ●Mustards are liquid agents with high persistence in temperate and cold climates ●Toxicity ○LCt50 vapor, inhalation (mg*min/m3) HD - 1500 HN1 - 1500 HN2 - 3000 HN3 - 1500
  • 35. Toxicity ●LCt50 vapor, skin (mg*min/m3) HD - 10000 HN1 - 20000 HN3 - 10000 ●LD50 liquid, skin (mg/kg) 1 hr contact time HD - 60 HN1 - 10 ●Total absorption of 6 µg/cm2 causes 50% of white human subjects to blister
  • 36. Mode of action ●Alkylating and electrophylic properties ●Modify the structure of nucleic acids, cellular membranes, and proteins ●Overall reactions of mustard with cellular molecules ●Used clinically as chemotherapy agents
  • 37. Signs and symptoms ●Cutaneous syndrome- divided into 4 phases
  • 38. Latent ●Skin penetration not noticed because painless ●Average duration of 4-8 hrs after exposure ●Duration of latent period dependent on humidity, temperature, and dose
  • 39. Erythema ●Intensive itching in association with erythema
  • 40. Vesication ●Begins 12 - 48 hours after exposure ●Coalescence of vesicles form large blisters ●Blisters generally more than 1 cm2 in area
  • 41. Necrosis ●Blisters rupture spontaneously turn into suppurating & necrotic wounds ●Prolonged period of healing of these wounds may take as long as weeks to months
  • 42. Ocular syndrome ●1-4 hours after exposure ●Intense pain, photophobia, and blepharospasm ●Usually blistering of external ocular structures and periorbital structures ●May result in blindness
  • 43. Respiratory tract ●Mustard attacks all mucous membranes ●Latent period 4-6 hours in duration ●Profuse nasal secretions, burning pain in throat ●Abundantly productive cough ●ARDS
  • 44. Gastrointestinal tract ●Nausea & vomiting ●Pain ●Bloody diarrhea ●Shock
  • 45. Systemic effects ●Headache, N/V, anorexia, epigastric pain, leukopenia, anemia ●CNS depression, seizures ●Cardiac arrythmias, Cardiac arrest
  • 46. Other Vesicants ●Lewisite ○Arsenical ○Similar clinical picture ○Reduced period of latency
  • 47. Halogenated oximes ●CX most toxic of this class of agents ●No period of latency ●Low boiling point limits this agents military usefulness
  • 48. Treatment ●Prevention of exposure ●Supportive care & meticulous nursing ●No specific therapy
  • 49. Choking Agents- History ●Phosgene(CG) first used combat in 1915 ●80% of all combat causalities in WWI ●CG is the only significant chemical threat in this class
  • 50. Physical & chemical properties ●Colorless gas under conditions of ordinary temperature & atmospheric pressure ●Odor of newly mown hay ●Limit of perception by smell 22 mg/m3
  • 51. Toxicity ●Minimal concentration irritation of eyes and throat 12.5-20 mg/m3 ●Serious lung damage-inhalation 50 mg/m3 over an hour period ●200 mg/m3 rapidly fatal ●LCt50 = 3000 mg*min/m3
  • 52. Mode of action ●Poorly understood=> diffuse damage to pulmonary membranes ●Severe pulmonary edema- 12-24 hrs post exposure ●Lethal exposure usually results in death within 24 hrs ●SurvivalX2-3 days=> good prognosis
  • 53. Signs and symptoms ●Immediate exposure symptoms ○Lacryamation, dry throat, coughing, tightness in chest ○Nausea & vomiting, headache ●Latent period of 2-6 hours after exposure ○Hypoxia, cyanosis, and productive cough ○Shock and respiratory arrest
  • 54. Treatment ●General supportive care ●Enriched O2 & ventilator support with PEEP for fulminant cases ●Rx the patient as an ARDS patient
  • 55. Cyanogen Agents- History ●Cyanogen halides only compounds of military importance ●WWI hydrocyanic acid & cyanogen chloride used by French ●Cyanogen bromide used by Austrians
  • 56. Properties ●Physical & Chemical ○Vapor at room temperature ○smell of "bitter almonds" ●Toxicity ○Percutaneous LD50 100mg/kg ○Ocular LD50 1-2 mg/kg ○Oral LD50 .9 mg/kg
  • 57. Haber's Law= LCt50 is a constant ●Blood agents do not follow Haber's Law ○LCt50 600 mg*min/m3 15 sec exposure ○LCt50 1000 mg*min/m3 60 sec exposure ○LCt50 2000 mg*min/m3 10 min exposure ○LCt50 4500 mg*min/m3 30 min exposure ●Time concentration variablity limit their military usefulness
  • 58. Mode of action ●Cyanide high affinity- Fe++ in ferric state ●Binds to cytochrome oxidase ●Inhibits electron transport chain ●Intracellular hypoxia ●O2 cannot be utilized within the cell ●Progressive severe Acidosis
  • 60. Treatment ●Amyl nitrate by inhalation ●Sodium nitrate(4-5 mg/kg or 10 ml 3% solution in 1 min) by infusion ●Converts hemoglobin=> methemoglobin ●Competes for cyanide ion
  • 61. Treatment ●Thiosulfate (50ml of a 25% aqueous solution(200 mg/kg)) ●Thiocyanate excreted in urine ●Hyperbaric oxygen adjunctive therapy for drug therapy
  • 62. Incapacitants- History Not known to be previously used in combat
  • 63. CNS Depressants ●BZ cholinergic compound ○Toxicology Dose ≤ 1mg/kg can cause delirium of several day duration Safety margin (lethal/incapacitating dose)= 30 ●Mode of action ○Similiar to atropine
  • 64. BZ- Signs & symptoms ●Dry as a bone ●Hot as a hare ●Mad as a hatter
  • 65. BZ- Treatment ●High risk for heat stroke as patient cannot sweat ●Physostigmine salicylate 1 mg/20 kg IM repeat dose in 40 min if inadequate result ●Maintenance dose 2-5 mg po q 1-2 hrs ●Titrate therapy to HR = 70-80 bpm
  • 66. Tetrahydrocannabinols ●Toxicity ○No deaths reported from this agent ○Synthetic analogs can have effects for days after dose ●Mode of action ○Unknown
  • 67. Tetrahydrocannabinols ●Signs & symptoms ○feelings of unreality, intensification of sensations, difficulty in concentration ○lethargy, sedation, orthostatic hypotension (synthetic analogs) ●Treatment ○No treatment necessary
  • 68. CNS Stimulants- LSD & Mescaline ●Toxicity ○D-lysergic acid diethylamide most potent biologicaly active indole ○Minimal dose 50 µgm ○Doses of 2-5 mg taken without sequelae ○Mescaline < potent toxic range 300-600 mg ○Max effects 2-3 hrs & further effects 4-8 hrs
  • 69. LSD ●LSD is a serotonin antagonist ●Enhances neural activity in the reticular activating system ○Signs & symptoms Sympathetic stimulation, Mental excitement ●Symptomatic treatment
  • 70. Conclusions ●Chemical threat is REAL ●Weapons are cheap to make & utilize ●Terrorist threat is OBVIOUSLY high ●Air Force Bases @ increased risk ●Poor weapon against prepared troops in the defense